QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 08:10 UTC · Public disclosure record

FBINTICKER

Fortune Brands Innovations, Inc.

BULLISH stock

Congress has disclosed 3 buys and 8 sells of FBIN (Fortune Brands Innovations, Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

3
Buy
8
Sell
-5
Net
3
Active politicians

Round-trip watch Still on the books

Members who disclosed buying FBIN and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.

MemberEntry (last buy)Entry priceNowvs entryStatus
Jefferson Shreve 2025-03-13 $58.12 $44.75 -23.0% underwater

Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Price & congressional trades
Buy Sell

Fundamentals · FY2026 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Materials. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/E
35.87
▲ pricier than Materials (median 19.8)
how it's calculated
P/E = price ÷ earnings per share
$44.75 ÷ $1.25 = 35.87
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
2.31
▼ cheaper than Materials (median 3.7)
how it's calculated
P/B = price ÷ book value per share
$44.75 ÷ $19.34 = 2.31
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

11 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Michael McCaul House SELL OCR ◆ insider divergence · strong Spouse 2026-08-20 16 days -3.6% $50K–$100K 82.7 ↗ filing
Michael McCaul House SELL OCR ◆ insider divergence · strong Spouse 2026-08-19 17 days -6.7% $15K–$50K 85.1 ↗ filing
Michael McCaul House SELL OCR ◆ insider divergence · strong Spouse 2026-06-18 17 days +25.5% $1K–$15K 88.8 ↗ filing
April McClain Delaney House SELL ◆ insider divergence · moderate Child 2026-05-07 25 days +0.7% $1K–$15K
<0.1% of NW
6.1 ↗ filing
April McClain Delaney House SELL ◆ insider divergence · moderate Child 2026-05-06 26 days -1.4% $1K–$15K
<0.1% of NW
7.3 ↗ filing
April McClain Delaney House SELL ◆ insider divergence · moderate Child 2026-04-24 7 days -3.9% $1K–$15K
<0.1% of NW
7.9 ↗ filing
April McClain Delaney House SELL Child 2025-10-31 1 days 0.0% $1K–$15K
<0.1% of NW
7.5 ↗ filing
April McClain Delaney House SELL Child 2025-10-29 3 days +2.1% $1K–$15K
<0.1% of NW
13.1 ↗ filing
Jefferson Shreve House BUY ◆ insider convergence Self · CRT - Standard Unit Trust 2025-03-13 15 days +1.3% $15K–$50K
<0.1% of NW
84.7 ↗ filing
April McClain Delaney House BUY ◆ insider convergence Child 2025-02-17 12 days -5.8% $1K–$15K
<0.1% of NW
32.9 ↗ filing
April McClain Delaney House BUY ◆ insider convergence Child 2025-02-08 21 days -5.2% $1K–$15K
<0.1% of NW
62.3 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in FBIN — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

3
Congress trades with insider convergence
6
…with insider divergence
18
Insider open-market trades

Of the congressional trades in FBIN, 3 coincided with corporate insiders moving the same way within 60 days, and 6 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-08-07 Novak Matthew Edward C-suite SELL $31K ↗ EDGAR
2026-08-07 Singh Jesse G C-suite BUY $996K ↗ EDGAR
2026-08-06 Singh Jesse G C-suite BUY $743K ↗ EDGAR
2026-08-06 Singh Jesse G C-suite BUY $276K ↗ EDGAR
2026-06-10 GARDEN EDWARD P Director BUY $13.0M ↗ EDGAR
2026-05-20 GARDEN EDWARD P Director BUY $196K ↗ EDGAR
2026-05-20 GARDEN EDWARD P Director BUY $2.0M ↗ EDGAR
2026-05-19 GARDEN EDWARD P Director BUY $13.5M ↗ EDGAR
2025-08-29 Novak Matthew Edward C-suite SELL $20K ↗ EDGAR
2025-08-18 Fink Nicholas I. C-suite SELL $89K ↗ EDGAR
2025-08-15 Fink Nicholas I. C-suite SELL $1.8M ↗ EDGAR
2025-03-04 Papesh Kristin Other BUY $30K ↗ EDGAR
2025-02-10 Wilson Ron C-suite SELL $103K ↗ EDGAR
2024-08-27 HACKETT ANN F Director SELL $174K ↗ EDGAR
2024-03-11 WATERS RONALD V Director SELL $162K ↗ EDGAR
2024-03-05 PHYFER CHERI M C-suite SELL $1.6M ↗ EDGAR
2023-06-09 HACKETT ANN F Director SELL $292K ↗ EDGAR
2023-06-09 HACKETT ANN F Director SELL $26K ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
Congress 2026-08-20 Michael McCaul SELL $50K–$100K
Congress 2026-08-19 Michael McCaul SELL $15K–$50K
◆ insider 2026-08-07 Novak Matthew Edward C-suite SELL $31K
◆ insider 2026-08-07 Singh Jesse G C-suite BUY $996K
◆ insider 2026-08-06 Singh Jesse G C-suite BUY $743K
◆ insider 2026-08-06 Singh Jesse G C-suite BUY $276K
Congress 2026-06-18 Michael McCaul SELL $1K–$15K
◆ insider 2026-06-10 GARDEN EDWARD P Director BUY $13.0M
◆ insider 2026-05-20 GARDEN EDWARD P Director BUY $196K
◆ insider 2026-05-20 GARDEN EDWARD P Director BUY $2.0M
◆ insider 2026-05-19 GARDEN EDWARD P Director BUY $13.5M
Congress 2026-05-07 April McClain Delaney SELL $1K–$15K
Congress 2026-05-06 April McClain Delaney SELL $1K–$15K
Congress 2026-04-24 April McClain Delaney SELL $1K–$15K
Congress 2025-10-31 April McClain Delaney SELL $1K–$15K
Congress 2025-10-29 April McClain Delaney SELL $1K–$15K
◆ insider 2025-08-29 Novak Matthew Edward C-suite SELL $20K
◆ insider 2025-08-18 Fink Nicholas I. C-suite SELL $89K
◆ insider 2025-08-15 Fink Nicholas I. C-suite SELL $1.8M
Congress 2025-03-13 Jefferson Shreve BUY $15K–$50K
◆ insider 2025-03-04 Papesh Kristin Other BUY $30K
Congress 2025-02-17 April McClain Delaney BUY $1K–$15K
◆ insider 2025-02-10 Wilson Ron C-suite SELL $103K
Congress 2025-02-08 April McClain Delaney BUY $1K–$15K

FAQ Common questions

How much has Congress traded FBIN?

3 disclosed buys and 8 sells of FBIN (Fortune Brands Innovations, Inc.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade FBIN?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.